2021
DOI: 10.22602/iq.9783943001686
|View full text |Cite
|
Sign up to set email alerts
|

Schlaganfallrehabilitation

Abstract: Goals: Mental representations of outcomes or end states that an individual wants to achieve. Underlying constructs: Goals (distal/proximal), Goal priority, Goal/target setting, Goals (autonomous/controlled), Action planning. Beliefs about consequences:Acceptance of the truth, reality or validity about outcomes of a behavior in a given situation. Underlying constructs: Beliefs, Outcome expectancies, Characteristic of outcome expectancies, Anticipated regret, Consequences.Reinforcement: Increasing the probabilit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…All analysis will be performed on STA R Max devices (Stago, Asnières-sur-Seine, France). As part of clinical routine in every AIS patient with either known negative or unknown DOAC status dTT will be determined and a LMWH-calibrated anti-Xa assay 51 will be performed as an initial screening tool to identify an anti-Xa activity below 0.35 U/mL, which for every DOAC translates into a concentration <30 ng/mL. In patients with known DOAC status, specific anti-IIa measurement via dTT or specific anti-Xa measurements will be run and the quantity of DOAC in the patient's plasma will be reported as concentration (ng/mL).…”
Section: Methodsmentioning
confidence: 99%
“…All analysis will be performed on STA R Max devices (Stago, Asnières-sur-Seine, France). As part of clinical routine in every AIS patient with either known negative or unknown DOAC status dTT will be determined and a LMWH-calibrated anti-Xa assay 51 will be performed as an initial screening tool to identify an anti-Xa activity below 0.35 U/mL, which for every DOAC translates into a concentration <30 ng/mL. In patients with known DOAC status, specific anti-IIa measurement via dTT or specific anti-Xa measurements will be run and the quantity of DOAC in the patient's plasma will be reported as concentration (ng/mL).…”
Section: Methodsmentioning
confidence: 99%